These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3362419)

  • 1. Dextromethorphan protects against cerebral infarction in a rat model of hypoxia-ischemia.
    Prince DA; Feeser HR
    Neurosci Lett; 1988 Mar; 85(3):291-6. PubMed ID: 3362419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia.
    Steinberg GK; Saleh J; Kunis D
    Neurosci Lett; 1988 Jun; 89(2):193-7. PubMed ID: 3292967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits.
    Steinberg GK; George CP; DeLaPaz R; Shibata DK; Gross T
    Stroke; 1988 Sep; 19(9):1112-8. PubMed ID: 3413809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits.
    Steinberg GK; Saleh J; Kunis D; DeLaPaz R; Zarnegar SR
    Stroke; 1989 Sep; 20(9):1247-52. PubMed ID: 2672427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextromethorphan protects against cerebral injury following transient, but not permanent, focal ischemia in rats.
    Britton P; Lu XC; Laskosky MS; Tortella FC
    Life Sci; 1997; 60(20):1729-40. PubMed ID: 9150412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextromethorphan attenuates post-ischemic hypoperfusion following incomplete global ischemia in the anesthetized rat.
    Tortella FC; Martin DA; Allot CP; Steel JA; Blackburn TP; Loveday BE; Russell NJ
    Brain Res; 1989 Mar; 482(1):179-83. PubMed ID: 2706475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextromethorphan reduces neocortical ischemic neuronal damage in vivo.
    George CP; Goldberg MP; Choi DW; Steinberg GK
    Brain Res; 1988 Feb; 440(2):375-9. PubMed ID: 3359222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia.
    Martin D; Chinookoswong N; Miller G
    Exp Neurol; 1994 Dec; 130(2):362-7. PubMed ID: 7867766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist.
    Tortella FC; Britton P; Williams A; Lu XC; Newman AH
    J Pharmacol Exp Ther; 1999 Oct; 291(1):399-408. PubMed ID: 10490930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile.
    Steinberg GK; Kunis D; DeLaPaz R; Poljak A
    Neurol Res; 1993 Jun; 15(3):174-80. PubMed ID: 8103583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture.
    Goldberg MP; Pham PC; Choi DW
    Neurosci Lett; 1987 Sep; 80(1):11-5. PubMed ID: 3658226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan alters cerebral blood flow and protects against cerebral injury following focal ischemia.
    Steinberg GK; Lo EH; Kunis DM; Grant GA; Poljak A; DeLaPaz R
    Neurosci Lett; 1991 Dec; 133(2):225-8. PubMed ID: 1816501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-response study of dextrorphan in permanent focal ischemia.
    Graham SH; Chen J; Simon RP
    Neurosci Lett; 1993 Sep; 160(1):21-3. PubMed ID: 8247325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AR-R15896AR reduces cerebral infarction volumes after focal ischemia in cats.
    Sutherland GR; Perron JT; Kozlowski P; McCarthy DJ
    Neurosurgery; 2000 Mar; 46(3):710-9; discussion 719-20. PubMed ID: 10719868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis.
    Pechnick RN; Poland RE
    J Pharmacol Exp Ther; 2004 May; 309(2):515-22. PubMed ID: 14742749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextromethorphan protects male but not female mice with brain ischemia.
    Comi AM; Highet BH; Mehta P; Hana Chong T; Johnston MV; Wilson MA
    Neuroreport; 2006 Aug; 17(12):1319-22. PubMed ID: 16951577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of morphinan drugs on haloperidol-induced catalepsy in rats: a comparative study with an N-methyl-D-aspartate antagonist.
    Scotti de Carolis A; Popoli P; Pezzola A; Sagratella S
    Arch Int Pharmacodyn Ther; 1991; 310():132-41. PubMed ID: 1685312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextromethorphan and neuromodulation: old drug coughs up new activities.
    Tortella FC; Pellicano M; Bowery NG
    Trends Pharmacol Sci; 1989 Dec; 10(12):501-7. PubMed ID: 2694543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextromethorphan and dextrorphan as calcium channel antagonists.
    Carpenter CL; Marks SS; Watson DL; Greenberg DA
    Brain Res; 1988 Jan; 439(1-2):372-5. PubMed ID: 2451974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dextromethorphan on regional cerebral blood flow in focal cerebral ischemia.
    Lo EH; Steinberg GK
    J Cereb Blood Flow Metab; 1991 Sep; 11(5):803-9. PubMed ID: 1874811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.